Success Metrics

Active Trials
2(67%)

Phase Distribution

Ph phase_1
3
100%

Phase Distribution

3

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
Phase 1Safety & dosage
3(100.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

3

all time

Status Distribution
Active(3)

Detailed Status

Recruiting2
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
2
Success Rate
N/A
Most Advanced
Phase 1

Trials by Phase

Phase 13 (100.0%)

Trials by Status

not_yet_recruiting133%
recruiting267%

Recent Activity

2 active trials
Showing 3 of 3
not_yet_recruitingphase_1

A Study of AK138D1 Alone or in Combination With Ivonescimab in Advanced Breast Cancer

NCT07560124
recruitingphase_1

A Study of AK138D1 in Advanced Malignant Tumors

NCT07281326
recruitingphase_1

A Phase I Study of AK138D1 in the Treatment of Advanced Solid Tumors

NCT06730386

Clinical Trials (3)

Showing 3 of 3 trials
NCT07560124Phase 1

A Study of AK138D1 Alone or in Combination With Ivonescimab in Advanced Breast Cancer

Not Yet Recruiting
NCT07281326Phase 1

A Study of AK138D1 in Advanced Malignant Tumors

Recruiting
NCT06730386Phase 1

A Phase I Study of AK138D1 in the Treatment of Advanced Solid Tumors

Recruiting

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3